Kinisis Ventures closed the final quarter of 2025 with its Fund I and Fund II portfolios demonstrating significant operational maturity and disciplined execution across the technology spectrum, ranging from artificial intelligence to biomaterials .
According to the venture capital firm’s year-end review, the period was defined by a transition toward sustainable revenue generation and clearer paths to international scale for its diverse group of investee companies.
At Threedium , the
